Thomas B. Stanley - Concepedia

Concepedia

Author

Thomas B. Stanley

Research Triangle Park Foundation

Also Known As

Lin, Pen Jen, Peter L. Callan, Stafford, D. W., T B Stanley, T. B. STANLEY, T. B. Stanley, T. Stanley, T.B. Stanley, Thomas B Stanley, Thomas B. STANLEY

58

Publications

4.6K

Citations

23

H-Index

76

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)University of North Carolina at Chapel Hill High Throughput Biology (United States)Duke University

TB

About

Thomas B. Stanley is an author at Research Triangle Park Foundation specializing in medicine, natural sciences, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	3.3K
2	Natural Sciences	12	12	3.1K
3	Biochemistry	12	12	3.2K
4	Engineering	2	2	209
5	Public Health	2	2	166

Thomas B. Stanley

×

26

Publications

4.6K

Citations

23

H-Index

	Year	Citations
Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition Randy K. Bledsoe, Valerie G. Montana, Thomas B. Stanley, Cell Crystal StructureSignal TransductionBiochemistryG Protein-coupled ReceptorNatural Sciences	2002	810
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα H. Eric Xu, Thomas B. Stanley, Valerie G. Montana, Nature Transcriptional RegulationBiochemistryMolecular RegulationNatural SciencesReceptor (Biochemistry)	2002	608
Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1<i>H</i>-indol-5-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) Jeffrey M. Axten, Jesús R. Medina, Yanhong Feng, Journal of Medicinal Chemistry Chemoprevention StrategyChemical BiologyPharmaceutical ChemistryTumor BiologyMolecular Pharmacology	2012	601
Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity Charity Atkins, Qi Liu, Elisabeth A. Minthorn, Cancer Research Tumor BiologySignaling PathwayUpr SignalingCell RegulationReceptor Tyrosine Kinase	2013	426
Structural Basis for Androgen Receptor Interdomain and Coactivator Interactions Suggests a Transition in Nuclear Receptor Activation Function Dominance Bin He, Robert T. Gampe, A.J. Kole, Molecular Cell Signal TransductionMolecular PhysiologyCoactivator InteractionsEndocrine MechanismHormonal Receptor	2004	289
Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development Jeffrey M. Axten, Stuart P. Romeril, Arthur Y. L. Shu, ACS Medicinal Chemistry Letters Drug Discovery ProgramTumor BiologyPhysical PropertiesMedicinal ChemistrySignaling Pathway	2013	224
A Ligand-mediated Hydrogen Bond Network Required for the Activation of the Mineralocorticoid Receptor Randy K. Bledsoe, Kevin P. Madauss, Jason A. Holt, Journal of Biological Chemistry	2005	209
Modulation of Androgen Receptor Activation Function 2 by Testosterone and Dihydrotestosterone Emily B. Askew, Robert T. Gampe, Thomas B. Stanley, Journal of Biological Chemistry Androgen ReceptorGynecologyMolecular BiologyReproductive BiologyTranscriptional Regulation	2007	202
Cenozoic stratigraphy and geologic history of southwestern Arizona L. D. EBERLY, Thomas B. Stanley Geological Society of America Bulletin Southwestern ArizonaSedimentary RecordCenozoic StratigraphyEngineeringStructural Geology	1978	193
A Structural and in Vitro Characterization of Asoprisnil: A Selective Progesterone Receptor Modulator Kevin P. Madauss, Eugene T. Grygielko, Su-Jun Deng, Molecular Endocrinology Vitro CharacterizationHormonal ContraceptiveProgesterone ReceptorGynecologyReproductive Biology	2007	148

Page 1